Background and Objectives Current benefits of invasive intracranial aneurysm treatment to
prevent aneurysmal subarachnoid hemorrhage (aSAH) rarely outweigh treatment risks. Most …

Background and Purpose: The prevalence of unruptured intracranial aneurysms (UIAs) in
the adult population is≈ 3%. Rupture of an intracranial aneurysm can have devastating …

Background Acetylsalicylic acid (ASA) and statins have been identified as potentially
reducing the risk of intracranial aneurysms (IA) rupture. We aim to determine the effect of this …

Objective: To evaluate the association between aspirin use and the risks of unruptured
intracranial aneurysm (UIA) growth and aneurysmal subarachnoid hemorrhage (aSAH) …

Background and Purpose—Knowledge about risk factors contributes to understanding the
pathophysiological mechanisms that cause intracranial aneurysm rupture and helps to …

Background Estimations of the intracranial aneurysm incidence require long-term follow-up
of a relatively large at-risk population; as a result, the incidence remains largely unknown …

Background The goal of the study was to analyse retrospectively the impact of risk factors for
subarachnoid haemorrhage (SAH) on the size of ruptured intracranial aneurysms in order to …

Background and Purpose—The presence of multiple intracranial aneurysms may be a sign
of significant risk factors for aneurysm formation that differ from those factors that increase …

Objective We initiated a multicenter, prospective cohort study to test the hypothesis that
aspirin is safe for patients with ischemic cerebrovascular disease (ICVD) harboring …

Purpose The study aimed to identify potential risk factors for aneurysm rupture by performing
a systematic review and meta-analysis. Materials and methods We systematically searched …